Phase Ib study of pembrolizumab and XL888 in patients with advanced colorectal cancer

被引：0
|
作者：
Alese, O. [1 ]
Gbolahan, O. B. [1 ]
McCook-Veal, A. [1 ]
Coleman, K. [1 ]
Greene, E. [1 ]
Horvat, N. [1 ]
Switchenko, J. [1 ]
Lesinski, G. [1 ]
El-Rayes, B. F. [2 ]
机构：
[1] Emory Univ, Winship Canc Inst, Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Univ Alabama Birmingham, Hematooncol Dept, Birmingham, AL USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
52P
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [1] Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies.
    Akce, Mehmet
    Alese, Olatunji B.
    Shaib, Walid Labib
    Wu, Christina Sing-Ying
    Lesinski, Gregory B.
    El-Rayes, Bassel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [2] Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies: Results of the dose-escalation phase
    Akce, Mehmet
    Alese, Olatunji B.
    Shaib, Walid Labib
    Wu, Christina
    Lesinski, Gregory B.
    El-Rayes, Bassel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [3] XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial
    Phillips, Maggie J.
    Alese, Olatunji B.
    Horvat, Natalie K.
    Greene, Emily
    Gbolahan, Olumide B.
    Coleman, Kathleen
    Doxie, Deon B.
    Parihar, Vaunita
    Mahdi, Zaid K.
    McCook-Veal, Ashley
    Switchenko, Jeffrey M.
    Diab, Maria
    Herting, Cameron J.
    Paulos, Chrystal M.
    El-Rayes, Bassel F.
    Lesinski, Gregory B.
    ONCOIMMUNOLOGY, 2025, 14 (01):
  • [4] A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)
    Weiss, Glen J.
    Waypa, Jordan
    Blaydorn, Lisa
    Coats, Jessica
    McGahey, Kayla
    Sangal, Ashish
    Niu, Jiaxin
    Lynch, Cynthia A.
    Farley, John H.
    Khemka, Vivek
    BRITISH JOURNAL OF CANCER, 2017, 117 (01) : 33 - 40
  • [5] A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)
    Glen J Weiss
    Jordan Waypa
    Lisa Blaydorn
    Jessica Coats
    Kayla McGahey
    Ashish Sangal
    Jiaxin Niu
    Cynthia A Lynch
    John H Farley
    Vivek Khemka
    British Journal of Cancer, 2017, 117 : 33 - 40
  • [6] Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer
    Fountzilas, Christos
    Bajor, David L.
    Mukherjee, Sarbajit
    Saltzman, Joel
    Witkiewicz, Agnieszka K.
    Maguire, Orla
    Minderman, Hans
    Nambiar, Ram
    Rosenheck, Hanna R.
    Knudsen, Erik S.
    Muhitch, Jason B.
    Abrams, Scott, I
    Wang, Chong
    Hutson, Alan D.
    Attwood, Kristopher
    Hicks, Karen A.
    Jurcevic, Jennifer A.
    Kalinski, Pawel
    Iyer, Renuka
    Boland, Patrick M.
    CLINICAL CANCER RESEARCH, 2021, 27 (24) : 6726 - 6736
  • [7] INVESTIGATING THE CLINICAL SAFETY, EFFICACY, AND IMMUNE MODULATION OF COMBINED XL888 AND PEMBROLIZUMAB IN METASTATIC GASTROINTESTINAL MALIGNANCIES
    Herting, Cameron
    Zhang, Yuchen
    Doxie, Deon
    Farren, Matthew
    Ware, Michael
    Alese, Olatunji
    Wu, Christina
    Shaib, Walid
    Akce, Mehmet
    Zaidi, Mohammad
    Ruggieri, Amanda
    Dhodapkar, Madhav
    Dhodapkar, Kavita
    Sarmiento, Juan
    Ahmed, Rafi
    Maithel, Shishir
    El-rayes, Bassel
    Lesinski, Gregory
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A202 - A203
  • [8] A phase Ib/II study of cetuximab and pembrolizumab in metastatic colorectal cancer
    Fountzilas, C.
    Mukherjee, S.
    Saltzman, J.
    Bajor, D.
    Muhitch, J.
    Abrams, S.
    Maguire, O.
    Minderman, H.
    Wang, K.
    Hutson, A.
    Hicks, K.
    Ventola, J.
    Kalinski, P.
    Iyer, R.
    Boland, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S140 - S140
  • [9] Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial
    Voisin, Allison
    Terret, Catherine
    Schiffler, Camille
    Bidaux, Anne-Sophie
    Vanacker, Helene
    Perrin-Niquet, Marlene
    Barbery, Maud
    Vinceneux, Armelle
    Eberst, Lauriane
    Stephan, Pierre
    Garin, Gwenaele
    Spaggiari, Dany
    Perol, David
    Grinberg-Bleyer, Yenkel
    Cassier, Philippe A.
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2111 - 2120
  • [10] Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
    Nanda, Rita
    Chow, Laura Q. M.
    Dees, E. Claire
    Berger, Raanan
    Gupta, Shilpa
    Geva, Ravit
    Pusztai, Lajos
    Pathiraja, Kumudu
    Aktan, Gursel
    Cheng, Jonathan D.
    Karantza, Vassiliki
    Buisseret, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (21) : 2460 - +
12345